Azienda Ospedaliera Antonio Cardarelli   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Naples Italy (1927)

Organization Overview

First Clinical Trial
2004
NCT00742248
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

A. Cardarelli Hospital, Naples | AORN A.CARDARELLI | Azienda Ospedaliera Antonio Cardarelli, Napoli | Cardarelli Hospital | Division of Hematology and Stem Cell Transplantation Unit, Ospedale A.Cardarelli, Napoli, Italy | Ospedale A.Cardarelli, Napoli, Italy | Ospedale Antonio Cardarelli, Napoli | Unita' di Pneumologia e Allergologia, Dipartimento di Medicina Respiratoria', A. Cardarelli Hospital, Naples, Italy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 4)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Renal Cell (Phase 4)

Colorectal Neoplasms (Phase 2)

Hepatitis, Chronic (Phase 3)

Infertility (Phase 4)

Infertility, Male (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Lymphoma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Syndrome (Phase 2)

Varicocele (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 10